Abstract
To investigate the atherosclerosis hypothesis in primary antiphospholipid syndrome (APS) we measured intima media thickness (IMT) of carotid arteries and other cardiovascular risk factors in 20 patients with primary APS (mean age 35±12 years) and in 20 age and sex matched controls (mean age 34±12 years). The frequency of smoking, hypertension and dyslipidaemia was similar in the two groups but plasma homocysteine was higher in primary APS (11.9±6.2 vs 8.2±3.4 µmol/L, p=0.037).
IMT was slightly greater in primary APS than controls at the carotid bifurcation (0.61±0.24 vs 0.48±0.09 mm, p=0.04) and internal carotid (0.52±0.22 vs 0.40±0.08, p=0.01). When split by age (<30 years, >40 years) these differences were mostly evident in the older age group at the carotid bifurcation (0.76±0.25 vs 0.55±0.06, p=0.0007) and internal carotid (0.63±0.25 vs 0.45±0.09, p=0.02) whereas no differences were seen in the younger age group. Atherosclerosis is a possibility in primary APS patients in their fourth decade of life or older.
INTRODUCTION
The thrombotic tendency of the antiphospholipid syndrome (APS) shares several pathways with atherosclerosis (1) . Most of the human data relating antiphospholipid antibodies (aPL) to atherosclerosis derive from studies on APS associated with systemic lupus erythematosus, where aPL variably discriminated patients with higher intima-media thickness (IMT) and/or focal plaques in carotid arteries (2) (3) (4) . IMT of carotid arteries detected by high-resolution ultrasound is an acceptable and reliable surrogate marker of sub-clinical atherosclerosis and correlates well with cardiovascular risk factors, prevalent and incident cardiovascular events (5) . With this methodology we have previously reported that IgG aCL titre independently predicted IMT of carotid arteries in patients with primary APS (6) . The present report evaluates whether premature atherosclerosis may represent a feature of primary APS.
MATERIAL AND METHODS

Patients
We investigated twenty patients with primary APS been followed-up for an average of 4±1.4 years. They were evaluated for a thrombotic event and were found to be positive for lupus anticoagulant (LA) and anticardiolipin antibodies (aCL) on two separate occasions six weeks apart. They all met the Sapporo Criteria for APS (7) . To keep the focus on vascular disease, females who had suffered miscarriages were not included in this cohort. MRI, Doppler Ultrasound, ECG and echocardiogram were used to diagnose thrombosis according to vascular bed involved. An equal number of healthy control subjects of similar age and sex matched the primary APS patients.
Their demographics and clinical features are presented in Table 1 .
Methods
Lupus anticoagulant (LA) was screened for by activated partial thromboplastin time, Elisa method (Bio-Rad, Oslo, Norway) as previously described (6). The upper limit of normal HC (mean + 3SD) was 13.3 µmol/L. This was calculated from 36 healthy subjects (10 male, 26 female) who were not homozygous for the methylentetrahydrofolate reductase C677→T mutation. The intra and inter-assay coefficient of variability were 6.6% and 7.5% respectively. Cholesterol, HDL, LDL and triglycerides were laboratory grade measurements.
Intima-media thickness measurement
Primary APS and healthy controls underwent a detailed ultrasound evaluation of the carotid arteries performed by an experienced angiologist (AM), using an Aloka 2000 sonograph equipped with a 5-10 MHz linear transducer. The image acquisition followed the well-validated Atherosclerosis Risk in Communities Study protocol (9). Intra-reader reproducibility was assessed in two ways. Firstly, the same carotid measurement was performed twice on 20 individuals yielding a coefficient of agreement of almost 97%. Secondly the same IMT measurements were performed six times on one individual over a 2-month period, yielding a coefficient of variability between 3-4% according to carotid segment under study. The study was carried out with ethics approval and all participants gave written consent before entering the study.
Statistics
Statistical analysis was carried out by the Prism statistical package. Mann-Whitney and Fischer's exact test were employed to compare distribution and frequencies between groups respectively.
Results
Most patients (90%) had medium to high positive serum IgG aCL ( Table 1 ).
The frequency of smoking, hypertension, diabetes and obesity was similar between patients and controls. Abnormalities of the lipid profile and plasma HC above the upper limit of normal (13µmol/L) were similar although mean plasma HC concentration was higher in primary APS than in controls (11.9±6.2 vs 8.2±3.4 µmol/L, p=0.037).
Overall, IMT was slightly greater at the bifurcation and internal carotid in primary APS compared to controls (Table 2) . By chance, our cohort had an equal number of participants below 31 (n=10) and above 40 (n=10) years of age. APS patients over 40 exhibited a thicker intima media than APS patients below 31 years of age in all carotid segments considered ( Table 2) .
Discussion
Atherosclerosis represents an important issue in primary APS because it may enhance the cardiovascular burden and further affect morbidity of affected patients, causing for instance renal artery stenosis with consequent hypertension, detected in 26% of APS patients (10) . Only two studies have assessed IMT in primary APS.
Bilora et al. (11) studied 45 patients with primary APS who had initially
presented with deep vein thrombosis and a similar number of age and sex matched thrombotic controls that had undergone venous occlusions for secondary causes. The two groups were similar with regards to other risk factors for atherosclerosis. All subjects were investigated by echo-colour doppler of the carotid arteries, femoral arteries, and abdominal aorta. Having defined an IMT of greater than 2 an atherosclerotic plaque, the authors did not find a different plaque prevalence between patients and controls concluding that atherosclerosis was not a feature of their primary APS cohort.
At variance, Medina et al. (12) investigated 25 patients with primary APS syndrome (PAPS) and found that carotid intima media was markedly thicker in their patients than in their age and sex matched controls. However, most of the patients in the Medina study (12) had other conventional risk factors for atherosclerosis, whether in isolation or combination that might have masked the atherogenic potential of aPL. Of our patients, only 5% had hypertension and 20% had hyperlipidaemia compared to the 35% and 53% respectively reported in Medina's cohort. Likewise, in the Bilora (11) study, 33% of their primary APS patients had hypertension, 17% diabetes mellitus and 29% hyperlipidaemia smokers.
Obesity was not present in any of our patients although 30% of our patients smoked (between 10-20 cigarettes per day) compared to the 10% from Medina et al. (12) and to the 37% from Bilora et al. (11) .
Amongst other vascular risk factors, we also measured plasma HC, the mean concentration of which was higher in primary APS than in the control group, although the proportion of participants with a HC above the upper limit of normal was not different. Poor disposal of plasma HC is linked with an earlier age at onset of first thrombotic event (13) and elevated plasma levels correlate to IMT in primary APS (6).
Neither Medina et al (12) nor Bilora et al (11) have mentioned the aPL titres of their patients. We had previously reported that IgG aCL strongly correlated to IMT of carotid arteries, and after correction for age and sex, IgG aCL emerged as an independent predictor IMT highlighting a possible specific dose effect of IgG aCL on IMT (6). The IMT, as measured by Medina et al (12) was much higher than in our patients and even their "healthy controls" (mean age of 41.7 years) showed a mean IMT of 1.2 mm, quite higher than what is generally reported in the literature for that age group (reviewed in 14). This is quite surprising and probably the result of their ultrasound method, which differed from ours. We have separately commented on their methodology (15) . None of our controls and only one of our primary APS patients had such a high reading. A possible age effect has not been taken into account in Medina's or Bilora's cohorts whereas we show that primary APS patients over 40 years of age have greater IMT than controls and than primary APS below 30 years of age, Unfortunately none of these studies can confirm or refute the hypothesis of premature atherosclerosis in primary APS. When compared to healthy controls, primary APS differ for three variables: the presence and persistence of aPL, the occurrence of thrombosis and ongoing oral anticoagulation. Bilora et al (11) correctly employed thrombotic controls, but these were patients who suffered deep vein thrombosis whose causes were unknown and whose duration of anticoagulation may not match that of primary APS. In addition, the authors focused mainly on the relationship between plaque frequency and cumulative positivity to three subpopulations of aPL, but not to their titre. We feel that the persistence of aPL should be compared to other conditions with a similar persistent risk such as inherited thrombophilia. This is the group on whom we are performing IMT measurements to match for age, sex, occlusive event and, where possible, timing of occlusive event and length of oral anticoagulation in order to compare our primary APS patients. The implication of atherosclerosis in primary APS is of such importance that any study attempting to assess its presence should be as controlled as possible to avoid confounding. In conclusion, our preliminary results would suggest premature atherosclerosis at least in older primary APS patients but require validation according to the abovementioned criteria. We hope to make these data available in the near future. 
